news-medical.net
Why one gut microbe is attracting attention in heart failure research
A multi-omic study links gut bacteria, microbial metabolites, and changes in heart function, pointing to biological relationships that could reshape how researchers investigate heart failure progression. Study: Gut microbiome shifts in chronic systolic heart failure are associated with disease severity and clinical improvement. Image Credit: Lightspring / Shutterstock A recent study published in the journal Nature Cardiovascular Research suggests that alterations in the gut microbiome in chronic systolic heart failure (HF) due to nonischemic cardiomyopathy (NICM) are associated with disease severity and clinical improvement. The researchers found that Bifidobacterium, some strains of which produced indole-3-propionic acid (IPA) in laboratory experiments, may play a role in HF. In particular, greater Bifidobacterium abundance was associated with milder disease and improved functional status, while higher circulating IPA and predicted microbial butyrate production were associated with milder HF measures. HF patients experience considerable morbidity and an increased risk of death. The condition is becoming more prevalent, and disease trajectories vary, while the mechanisms underlying disease progression remain poorly understood. The gut microbiome contributes to several biological pathways, but its role in chronic HF remains unclear. Most previous studies were cross-sectional, with small sample sizes and limited functional profiling. About the study In the present...